Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 2 days agoNovavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 1 day agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company...
5 takeaways from Dr. Anthony Fauci's new memoir
Yahoo News· 13 hours agoIn “On Call: A Doctor's Journey in Public Service,” the nation’s former top infectious disease expert recounts how he helped guide the country through...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 6 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe double-blinded, randomised trial will compare CVXGA's efficacy, safety, and immunogenicity...
COVID/Flu Experimental Vaccine Receives Positive R | Newswise
Newswise· 2 days agoA vaccine that could offer protection against COVID-19 and the flu has received positive results during trials.According ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoThey have tips on what you need to know this season. (Getty Images) Vera Vita via Getty Images It’s...
Gateway - Quartz
Quartz· 15 hours agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19< ...